Adjuvant gemcitabine in case of carcinoma of pancreas. A case report

This report describes a case of a 53 year old man who presented with a diagnosis of carcinoma head of pancreas, and initially underwent surgery. Since carcinoma of pancreas has a high recurrence rate even after surgery, the patient was offered Gemcitabine [1000mg/m2, weekly for 7 weeks, then 1 week of rest followed by once weekly for 3 weeks, then rest week every 4 weeks]. He received 16 doses of gemcitabine. There was absolutely no grade 3 or 4 toxicity nor any delays, reductions or omission of doses. Post treatment CT scans showed no evidence of recurrence and patient is in good health 15 months post chemotherapy